NetworkNewsBreaks – Delic Holdings Corp.’s (CS
Post# of 135
Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has become one of a few U.S.-based ketamine therapy providers to offer Medicare coverage to patients at eight KWC clinics across the country. Under Medicare, KWC is accepting a limited number of patients for ketamine infusion therapy at Chicago, Denver, Houston, Jacksonville, Minneapolis, Tucson, Salt Lake City and Seattle clinics. In addition, KWC is providing the FDA-approved SPRAVATO(R) esketamine treatment at Houston, Jacksonville and Seattle locations for patients meeting the criteria for insurance coverage. “At Ketamine Wellness Centers it has been our mission from day one to make these life-changing therapies more accessible and affordable, which is why we are very focused on securing major insurers such as Medicare,” said Kevin Nicholson, CEO of Delic and KWC. “Many insurance organizations around the country continue to classify ketamine as ‘experimental’ allowing them to resist covering patients of many other ketamine clinics who, unlike KWC, do not have specialized in-house insurance teams. This has left tens of millions of Americans to suffer needlessly, and often dangerously, from mental health conditions and pain with no access to affordable effective treatments. KWC’s introduction of Medicare and other major insurance plan coverage overcomes a huge obstacle to the majority of mental health and pain patients previously forced to forego this safe, effective treatment because they cannot afford to pay out of pocket. Our team is working hard to bring Medicare and other insurance coverage to the rest of our clinics across the country so more people can access the quality care they need.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer